Another biopharma executive went before Congress to explain drug price hikes. Unlike Martin Shkreli, Mylan CEO Heather Bresch actually answered questions. Taking heat over the EpiPen scandal, she tried to stick to her script, getting testy when legislators brought up... Read more »
Tobacco is still king in North Carolina, the top crop in the nation’s largest tobacco-producing state. But these days, North Carolina tobacco means more than cigarettes.
Medicago’s facility in Durham, NC, for example, manufactures vaccines from tobacco plants. And a... Read more »
Farmers have tinkered with soil for thousands of years, using fertilizers to add nutrients and amendments to adjust its acidity. But soil is more complex than that, says Wayne Honeycutt, CEO of the Soil Health Institute in Research Triangle Park, NC.... Read more »
A core tenet of Xconomy—and the reason behind our broad coverage across information technology, life sciences, energy, and more—is that the most interesting and important innovations often arise from the intersection of different disciplines.
One of the most important intersections today... Read more »
Think “innovation” and you might picture some scrappy entrepreneurs toiling away in a kitchen or garage, hoping the landlord doesn’t notice what they’re up to. But the reality is that turning science into big business often requires far more sophisticated infrastructure—and... Read more »
Across the nation, and even looking back into the past, health was in the headlines this week. Our presidential candidates were either recovering from pneumonia or talking up their health records. New documents came to light that showed the sugar... Read more »
For people dealing with the creeping blindness of glaucoma, the most effective treatments are eye drops called prostaglandin analogues, or PGAs. They’re not a cure, but taken chronically, they’re the best way to slow the progression of the disease, which is... Read more »
A first-of-its-kind fund has launched with the mission to increase diversity in the tech industry by removing financial barriers and increasing access to tech education for anyone interested in pursuing it. The Tech Opportunity Fund is a partnership between the Iron... Read more »
[Corrected, 9/12/16, 4:28 p.m. See below.] What do cancer experts want? The moon, perhaps. As part of the Obama administration’s “cancer moonshot” program, a panel of scientists this week presented a set of broad, ambitious recommendations to speed up... Read more »
The Obama administration wants to speed up cancer research with its “Cancer Moonshot” program—packing 10 years’ worth of work on prevention and treatment programs into five is one of its rallying cries. Agreeing on what to do, and how to do... Read more »
Thanks to remarkable results in a small group of patients, including former U.S. President Jimmy Carter, cancer immunotherapy has spurred talk of once impossible-to-imagine cures and has gained its share, perhaps more than its share, of hype.
But immunotherapy is... Read more »
The attempt to commercialize gene therapy has been a multi-decade roller coaster, but its current upswing continues. Today Allergan, a company best known for skin and eye care products, has acquired a startup developing gene therapies for a range of eye... Read more »
After signaling that it plans to operate drones via cellular technologies, San Diego-based Qualcomm says today it is working with AT&T to use commercial wireless networks for test flights beyond an operator’s visual line of sight.
Qualcomm said in April it... Read more »